BACKGROUND Data on the clinical outcomes of percutaneous coronary intervention (PCI) for unprotected left main artery (LMCA) in patients with acute syndrome (ACS) are limited. Therefore, this study aimed to assess outcome ACS who underwent PCI LMCA culprit lesion.Methods and Results:Of 1,809 enrolled Assessing Optimal Percutaneous Coronary Intervention (AOI-LMCA) registry (a retrospective 6-cen...

conclusions although by current treatments, the prevalence of patients with low tc, ldl-c and non-hdl-c has significantly increased; dyslipidemia persisted in a considerable proportion of patients. these results necessitate further investigations into the relationship between high serum lipids and long-term outcome of patients after pci as well as further evaluations of the dyslipidemia treatme...

Objectives: This study aimed to investigate the efficacy of calcitriol on Ischemia-reperfusion Injury (IRI) and inflammatory biomarkers in patients with non-ST-segment elevation acute coronary syndromes (NSTEACS) undergoing elective Percutaneous Coronary Intervention (PCI). Methods: A total of 72 patients with NSTEACS were randomly divided into two groups: (1) the calcitriol-treated grou...

OBJECTIVES We explored the effect of timing of percutaneous coronary intervention (PCI) in acute coronary syndromes (ACS) without persistent ST-segment elevation on the need for repeat revascularization, and we related this effect to other events. BACKGROUND Percutaneous coronary intervention is widely used to treat ACS without persistent STsegment elevation. Moreover, restenosis and subsequent...

We report the case of a 78-year-old woman with saphenous vein graft (SVG) disease and chronic total occlusion (CTO) in three native coronary arteries [left anterior descending artery (LAD), left circumflex artery, and the right coronary artery], who was successfully treated by percutaneous coronary intervention (PCI) using the retrograde approach via the critically degenerated SVGs. The patient...

Background-—Adjunctive thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) was reported to promote better coronary and myocardial reperfusion. However, long-term mortality benefit of TA remains controversial. The objective of this study is to investigate the clinical impact of TA on long-term clinical outcomes in patients with ST-segment elevation myocardial infarct...

The routine use of vasodilators in patients with acute coronary syndromes or other groups undergoing percutaneous coronary intervention (PCI) cannot be recommended at present. However, in the event of no-reflow occurring following PCI, intracoronary adenosine or verapamil should be administered.

Coronary artery disease with left main stenosis is associated with the highest mortality of any coronary lesion. Studies in the 1970s and 1980s comparing coronary artery bypass grafting (CABG) and medical therapy showed a significant survival benefit with revascularization. In the angioplasty era, initial experience with percutaneous intervention was associated with poor clinical outcomes. As a...

Background: This study was conducted to analyze the influences of stent surface area (SSA), platelet distribution width (PDW), and joint effect these 2 risk factors on major adverse cardiovascular events (MACEs) in patients treated with percutaneous coronary intervention (PCI) together drug-eluting (DES) implantation.

Over the last three decades, percutaneous coronary intervention (PCI) technology has revolutionized the field of cardiology. PCI began in the form of balloon angioplasty, and was followed by coronary stenting. In-Stent restenosis is the main limitation of coronary stenting, and has been delayed to some extent by the development of drug eluting stents. Coronary angioplasty with stenting is curre...